Low-Flow, Low-Gradient AS Conclusion Builder

Low-Flow, Low-Gradient AS Conclusion Builder

Core Echo Inputs

AVA (cm²) Indexed AVA (cm²/m²) Vmax (m/s) Mean gradient (mmHg) Dimensionless Index (LVOT/AV VTI or Vpeak)

LV & Flow

LVEF (%) Stroke Volume Index (mL/m²) Body Surface Area (m²)

Confirmatory Testing

Sex for CT AU threshold — Female (true severe ≥ 1200 AU) Male (true severe ≥ 2000 AU) CT Aortic Valve Calcium (Agatston units)

DSE (for reduced EF)

DSE performed DSE shows AVA ≤ 1.0 cm² with rise in gradient (true severe) DSE shows AVA increases > 1.0 cm² (pseudo-severe)

Copied!

Conclusion text

Tips: LF-LG pattern requires AVA ≤ 1.0 cm² (or indexed ≤ 0.6), mean gradient < 40 mmHg, Vmax < 4.0 m/s, and SVI < 35 mL/m². Classical = LVEF < 50%; paradoxical = LVEF ≥ 50%. True severe confirmed by DSE (classical) or CT calcium (paradoxical).

Aortic Stenosis- Including Classical vs. Paradoxical Low-Flow, Low-Gradient Severe Aortic Stenosis

REST — Echo inputs

LVOT diameter (cm)

LVOT VTI (cm)

Aortic valve VTI (cm)

LVOT Vmax (m/s)

Aortic valve Vmax (m/s)

Mean gradient (mmHg)

LVEF REST (%)

Enter any combination (VTI and/or Vmax). Mean gradient and EF are optional but useful.

Patient / Flow options (optional)

BSA (m²)

Height (cm)

Weight (kg)

Heart rate REST (bpm)

Ejection time REST (ms)

Systolic fraction (if no ET)

Flow \(Q\) uses ET if provided (Q = SV/ET). Otherwise estimates with HR and systolic fraction.

Continuity: AVA = LVOT area × (LVOT VTI / AV VTI) or × (LVOT Vmax / AV Vmax)

Results

Ready-made report sentence

Rapid Sedation in Intubated Patients

Rapid Sedation Options in the ICU

This reference guide outlines commonly used medications for rapid sedation in intubated ICU patients. All styles are inline to ensure your blog formatting is preserved.

Drug	Typical Dose	Onset	Advantages	Cautions
Fentanyl	25–100 mcg IV bolus; may repeat q30–60 min PRN	1–2 min	Rapid analgesia, minimal hemodynamic impact at lower doses	Respiratory depression, chest wall rigidity with rapid/high doses
Propofol (IV Push)	10–30 mg IV bolus, repeat 10–20 mg q1–2 min PRN	Seconds	Rapid onset, short duration, easy titration	Hypotension, bradycardia, apnea if overdosed
Midazolam (Versed)	1–2 mg IV q2–3 min, titrate slowly	2–3 min	Synergistic with opioids, useful for anxiety/withdrawal	Respiratory depression, especially with opioids
Ketamine	0.5–1 mg/kg IV push	1–2 min	Preserves airway reflexes, bronchodilation	Emergence reaction, ↑HR/BP, caution in CAD
Dexmedetomidine	0.5 mcg/kg over 10 min (optional), then 0.2–0.7 mcg/kg/hr	5–10 min	Minimal respiratory depression, cooperative sedation	Bradycardia, hypotension, avoid rapid bolus
Haloperidol	2.5–5 mg IV/IM q15–30 min (max ~20 mg)	10–20 min	No respiratory depression, familiar agent	QTc prolongation, EPS, dystonia
Droperidol	2.5–5 mg IV/IM, repeat q15 min (max 10 mg)	5–10 min	Short half-life, rapid control of delirium	QTc ↑, baseline ECG needed
Olanzapine	10 mg IM (not IV)	15–30 min	Less EPS than haloperidol	Somnolence, avoid with IM benzos

Note: Always titrate to desired effect, monitor hemodynamics and respiratory function, and reassess sedation goals frequently.

Rapid Sedation in Intubated Patient

Rapid Sedation Options in the ICU

This reference guide outlines commonly used medications for rapid sedation in intubated ICU patients. All styles are inline to ensure your blog formatting is preserved.

Drug	Typical Dose	Onset	Advantages	Cautions
Propofol (IV Push)	10–30 mg IV bolus, repeat 10–20 mg q1–2 min PRN	Seconds	Rapid onset, short duration, easy titration	Hypotension, bradycardia, apnea if overdosed
Midazolam (Versed)	1–2 mg IV q2–3 min, titrate slowly	2–3 min	Synergistic with opioids, useful for anxiety/withdrawal	Respiratory depression, especially with opioids
Ketamine	0.5–1 mg/kg IV push	1–2 min	Preserves airway reflexes, bronchodilation	Emergence reaction, ↑HR/BP, caution in CAD
Dexmedetomidine	0.5 mcg/kg over 10 min (optional), then 0.2–0.7 mcg/kg/hr	5–10 min	Minimal respiratory depression, cooperative sedation	Bradycardia, hypotension, avoid rapid bolus
Haloperidol	2.5–5 mg IV/IM q15–30 min (max ~20 mg)	10–20 min	No respiratory depression, familiar agent	QTc prolongation, EPS, dystonia
Droperidol	2.5–5 mg IV/IM, repeat q15 min (max 10 mg)	5–10 min	Short half-life, rapid control of delirium	QTc ↑, baseline ECG needed
Olanzapine	10 mg IM (not IV)	15–30 min	Less EPS than haloperidol	Somnolence, avoid with IM benzos

Note: Always titrate to desired effect, monitor hemodynamics and respiratory function, and reassess sedation goals frequently.

Hyperthermia- thinking outside the box: Drug Fevers

Drug class / toxidrome	Representative agents	Heat-generation mechanism	Key clinical clues
Sympathomimetic stimulants	Cocaine / crack; amphetamine salts (dextro- / lisdexam-); methamphetamine; MDMA / ecstasy; synthetic cathinones (“bath salts”); PCP; ketamine	Massive catecholamine surge → agitation, intense muscle activity, ↑ metabolic rate	Profuse sweating, mydriasis, severe tachycardia / HTN; rhabdo common
Anticholinergic agents	Atropine, scopolamine; diphenhydramine / doxylamine; tricyclics (amitriptyline); benztropine, trihexyphenidyl; oxybutynin, tolterodine	Inhibits sweating → impaired heat dissipation while metabolic heat production continues	Hot dry skin, delirium, urinary retention, dry mucosa, mydriasis
Mitochondrial uncouplers	High-dose salicylates (aspirin, oil of wintergreen); 2,4-dinitrophenol (DNP); pentachlorophenol	Uncouples oxidative phosphorylation → 100 % of energy released as heat	Hyperpnea, mixed metabolic + resp alkalosis; temp can climb extremely fast
Excess thyroid hormone / thyroid storm	Levothyroxine OD (intentional / iatrogenic); decompensated Graves’ disease	Marked ↑ basal metabolic rate throughout body tissues	Hyperpyrexia with severe tachyarrhythmia, tremor, altered mental status
Methylxanthines & related CNS stimulants	Theophylline (toxic levels), aminophylline, concentrated caffeine powders / tablets	β-adrenergic stimulation, seizures, continuous muscle activity	Tremor, vomiting, SVT / VT, hyperthermia
“Drug-fever” (immune-mediated)	β-lactams, sulfonamides, vancomycin; phenytoin, carbamazepine; allopurinol; heparin	Cytokine-mediated reset of thermoregulatory set-point	Usually < 40 °C; may look well after antipyretic; rash or eosinophilia possible

Bedside Pearls

• Pattern recognition matters:
  • Dry, flushed skin → anticholinergic.
  • Sweaty, hypertensive, wildly agitated → sympathomimetic.
  • Hyperpnea + high anion-gap acidosis → salicylate.
• Active cooling is urgent: ice packs, mist-and-fan, cool IV fluids; consider internal cooling if T > 41 °C.
• Benzodiazepines early for any stimulant-driven hyperthermia—reduce muscle activity and catecholamine surge.
• Salicylate OD: serum/urine alkalinization, whole-bowel irrigation (enteric-coated), hemodialysis if level > 100 mg/dL, severe acidosis, or AMS.
• DNP toxicity: deteriorates in minutes; no specific antidote—maximize cooling; dantrolene or ECMO used experimentally.
• Thyroid storm: β-block (esmolol), thionamide (PTU / methimazole), iodide, hydrocortisone, aggressive cooling.

Sepsis Definitions

Classic (1991/2001 “Sepsis-2”) Definitions

Stage	Diagnostic Criteria
Sepsis	Suspected or proven infection plus ≥ 2 SIRS criteria: Temp > 38 °C or < 36 °C HR > 90 beats min-1 RR > 20 min-1 or PaCO₂ < 32 mm Hg WBC > 12 × 109/L, < 4 × 109/L, or > 10 % bands
Severe Sepsis	Sepsis plus acute organ dysfunction, hypoperfusion, or hypotension. Typical examples: lactate > 2 mmol L-1; SBP < 90 mm Hg or MAP < 70; Cr ≥ 2 mg dL-1 or UO < 0.5 mL kg-1 h-1; bili ≥ 2 mg dL-1; platelets < 100 × 109/L; INR > 1.5; PaO₂/FiO₂ ≤ 300.
Septic Shock	Severe sepsis with persistent arterial hypotension despite adequate fluid resuscitation (conventionally ≥ 30 mL kg crystalloids) and requiring vasopressors.

Modern (2016 “Sepsis-3”) Definitions

Stage	Diagnostic Criteria
Sepsis	Suspected or documented infection plus acute organ dysfunction, quantified as an increase in SOFA score ≥ 2 points from baseline. (Outside the ICU, a quick screen — qSOFA ≥ 2: altered mentation, RR ≥ 22, SBP ≤ 100 mm Hg — signals need for full SOFA work-up.)
Septic Shock	Sepsis with both: 1) Vasopressor-dependent hypotension to maintain MAP ≥ 65 mm Hg and 2) Serum lactate > 2 mmol L-1 despite adequate fluid resuscitation. This subset carries ≈ 40–50 % mortality.

Sepsis Tables

1️⃣ Diagnostic Performance – SIRS vs Biomarker Combinations

Index Test (common cut‑off)	Sensitivity	Specificity	Key Source(s)
SIRS ≥ 2 criteria	0.83 – 0.88	0.29 – 0.49	Large SRs >60k pts
SIRS + Lactate ≥ 2 mmol L‑1	0.74 – 0.77	0.45 – 0.50	ED cohorts, 2023 meta‑analysis
SIRS + Lactate ≥ 3 – 3.5	≈0.67	≈0.71	Prospective ED study
SIRS + CRP ≥ 100 mg L‑1	0.70 – 0.80	≈0.70	CRP meta‑analysis
SIRS + Procalcitonin ≥ 0.5 ng mL‑1	0.77 – 0.80	0.72 – 0.79	2019 & 2023 SRs

Clinical take‑aways: Use SIRS (or NEWS) at triage for sensitivity, then layer procalcitonin ± lactate to rule‑in high‑risk patients; CRP is fallback when PCT isn’t available.

2️⃣ Sepsis Definitions – Classic vs Modern

Framework	Stage	Diagnostic Criteria
Sepsis‑2 (1991/2001)	Sepsis	Suspected infection + ≥2 SIRS signs
	Severe Sepsis	Sepsis + acute organ dysfunction (e.g., lactate >2, Cr ≥2, PLT <100, etc.)
	Septic Shock	Severe sepsis with persistent hypotension despite fluids, requiring vasopressors
Sepsis‑3 (2016)	Sepsis	Suspected infection + ΔSOFA ≥2 (acute organ dysfunction)
	Septic Shock	Sepsis with vasopressor‑dependent MAP <65 and lactate >2 mmol L‑1 post‑resuscitation

⚠️ Severe sepsis was retired in Sepsis‑3; infection + organ dysfunction is now simply called sepsis.

3️⃣ SOFA Score Matrix

Organ System	0 pts	1 pt	2 pts	3 pts	4 pts
Respiratory (PaO2/FiO2)	≥ 400	< 400	< 300	< 200 + support	< 100 + support
Coagulation (Platelets ×10³/µL)	≥ 150	< 150	< 100	< 50	< 20
Liver (Bilirubin mg/dL)	< 1.2	1.2–1.9	2.0–5.9	6.0–11.9	≥ 12.0
Cardiovascular	MAP ≥ 70	MAP < 70	Dopamine ≤ 5 µg/kg/min or any Dobutamine	Dopamine > 5 or Epi/NE ≤ 0.1 µg/kg/min	Dopamine > 15 or Epi/NE > 0.1 µg/kg/min
CNS (GCS)	15	13–14	10–12	6–9	≤ 5
Renal (Creat mg/dL or UO)	< 1.2	1.2–1.9	2.0–3.4	3.5–4.9 or UO < 500 mL/d	≥ 5.0 or UO < 200 mL/d

How to use:

1. Collect worst values for each domain in 24 h.
2. Assign subscores and sum (0–24).
3. ΔSOFA ≥2 with infection = sepsis per Sepsis‑3.

4️⃣ First‑Hour (“Golden Hour”) Sepsis Bundle

Action	Target Timeline	Details
Measure serum lactate	Within 1 hour	Remeasure in 2–4 h if initial >2 mmol L‑1
Obtain blood cultures before antibiotics	Within 1 hour	≥2 sets (aerobic + anaerobic) from separate sites
Administer broad‑spectrum antibiotics	<1 hour (ASAP)	De‑escalate once pathogen & sensitivities known
Give IV crystalloid bolus	Start in 1 hour; complete 30 mL/kg in <3 hours	Use balanced solution when available; reassess fluid responsiveness
Apply vasopressors	Immediately after fluids if MAP <65	First‑line: Norepinephrine; add Vasopressin/EPi as needed
Assess perfusion & organ function	Continuous	qSOFA, urine output, capillary refill, lactate trend

Initiate the bundle as soon as infection + organ dysfunction are suspected; delays >1 h correlate with stepwise mortality increases.